A fragment-based approach to developing inhibitors of the cryptic pocket of the Polo-Like Kinase 1 Polo-Box Domain.
Kunciw, D.L., De Fusco, C., Rossmann, M., Stokes, J.E., Renzetti, A., Sore, H.F., Hyvonen, M., Spring, D.R.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Serine/threonine-protein kinase PLK1 | 232 | Homo sapiens | Mutation(s): 0 Gene Names: PLK1, PLK EC: 2.7.11.21 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P53350 (Homo sapiens) Explore P53350 Go to UniProtKB: P53350 | |||||
PHAROS: P53350 GTEx: ENSG00000166851 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P53350 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
Z24 Query on Z24 | B [auth A] | (3~{R},5~{R})-1-[2,4-bis(fluoranyl)phenyl]-5-oxidanyl-pyrrolidine-3-carboxylic acid C11 H11 F2 N O3 HKKAZODAIOIPGM-LHLIQPBNSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 33.36 | α = 90 |
b = 93.38 | β = 100.72 |
c = 35.9 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
xia2 | data reduction |
xia2 | data scaling |
PHASER | phasing |